Michael W. Fried

North Carolina Hepatitis B Research Network

National Institute of Diabetes and Digestive and Kidney Diseases · U01

Contact PI · $3.4M · Univ of North Carolina Chapel Hill

Mentoring Junior Faculty: Viral Hepatitis Clinical Research

National Institute of Diabetes and Digestive and Kidney Diseases · K24

Contact PI · $1.5M · Univ of North Carolina Chapel Hill

A Phase I/II Randomized, Placebo Controlled Trial of Silymarin for Hepatitis C

National Center for Complementary and Integrative Health · U01

Contact PI · $823.7K · Univ of North Carolina Chapel Hill

General Clinical Research Center

National Center for Research Resources · M01

Project lead · $392.5K · Univ of North Carolina Chapel Hill

Evaluation of Serum Chemokines for Patients Undergoing Treatment With Boceprevir.

Principal investigator · Withdrawn

University of North Carolina, Chapel Hill

HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network

Principal investigator · Completed

University of North Carolina, Chapel Hill

Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment

Principal investigator · Completed · Phase 2

National Center for Complementary and Integrative Health (NCCIH)

Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis

Principal investigator · Completed · Phase 2

Madaus Inc